Muken Ross purchased $137K of SOPH
Muken Ross (Chief Executive Officer) purchased 20,000 shares of SOPHiA GENETICS SA (SOPH) at $6.86 ($0.14M total) on 2026-11-06.
How this was made
The 30-second read
Why it matters
The modest buy may be interpreted as a positive signal but is unlikely to move the stock significantly given its small size.
Market read
First‑report insider purchase provides a small but fresh data point for traders monitoring SOPH.
Timing
post‑market today
Background
SEC Form 4 filing discloses insider transactions. The CEO's purchase is the first public report of this trade.
Ticker impact
CEO Muken Ross bought 20,000 SOPH shares for $137,188, raising his stake to 680,391 shares.
likely slight upward pressure as market prices in the insider buy
Form 4 is a primary source; the purchase is modest but signals confidence from the CEO.
Key entities
- companySOPHiA GENETICS SA
Swiss biotech firm listed on NASDAQ under SOPH.
- personMuken Ross
Chief Executive Officer of SOPHiA GENETICS.



